Hemostatic agent "Chitostat" made primarily of chitosan released.
Medikit Co., Ltd. (Headquarters: Bunkyo-ku, Tokyo, President: Yoji Kageyama) is pleased to announce that it has started selling the hemostatic agent "Chitosan" (hereinafter referred to as "the product"), which is primarily composed of chitosan, as of November 1, 2021. The main component of this product is chitosan. It is expected that the positive charge of chitosan will attract the negatively charged platelets in the blood, promoting platelet aggregation. This product was developed in collaboration with Koyo Chemical Co., Ltd. (Headquarters: Kita-ku, Osaka, President: Akira Haku), a comprehensive manufacturer of chitin-related products, and Shintac Kasei Co., Ltd. (Headquarters: Mitoyo City, Kagawa Prefecture, President: Katsumi Kurokawa), a comprehensive processing manufacturer of adhesive products such as tape. Chitosan is a type of cationic dietary fiber that is a high molecular weight polysaccharide.
Inquiry about this news
Contact Us Online